[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363552-105":59,"doc-detail-363552-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","developing-blood-extracellular-vesicle-protein-biomarkers-for-hepatocellular-carcinoma-mechanisms-methods-and-translation","Developing blood extracellular vesicle protein biomarkers for hepatocellular carcinoma - mechanisms, methods, and translation","","Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally, driven by late-stage diagnoses caused by the absence of early clinical symptoms and limited sensitivity of current diagnostic tools. Circulating extracellular vesicles (EVs) naturally carry proteins and nucleic acids, reflecting tumor-specific biology and early pathophysiological changes, enabling a noninvasive liquid biopsy strategy. This review synthesizes mechanistic insights into EV-associated proteins with proteomic approaches for biomarker discovery, validation, and clinical translation across large patient cohorts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/developing-blood-extracellular-vesicle-protein-biomarkers-for-hepatocellular-carcinoma-mechanisms-methods-and-translation/363552/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/developing-blood-extracellular-vesicle-protein-biomarkers-for-hepatocellular-carcinoma-mechanisms-methods-and-translation/363552.png","ImageObject",300,407,{"name":92,"@type":93},"Aran","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are early detection tools for hepatocellular carcinoma still insufficient?","Question",{"text":112,"@type":113},"HCC is often diagnosed at intermediate or advanced stages because early clinical symptoms are insidious and current diagnostic tools lack sufficient sensitivity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do blood extracellular vesicles support noninvasive biomarker discovery?",{"text":117,"@type":113},"Circulating EVs naturally transport proteins and nucleic acids that reflect tumor-specific biology and early pathological changes, making them suitable reporters for liquid biopsy.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review cover to advance EV protein biomarkers toward clinical translation?",{"text":121,"@type":113},"It integrates mechanistic advances on EV-associated proteins with state-of-the-art proteomic methods for discovery, validation, analytical profiling in cohorts, and development of high-throughput detection platforms such as biochip-based assays.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363552,1790594637,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Zhuang et al. Journal of Nanobiotechnology (2026) 24:515  \n[https://doi.org/10.1186/s12951-026-04463-6](https://doi.org/10.1186/s12951-026-04463-6)  \nJournal of Nanobiotechnology  \nREVIEW Open Access  \nDeveloping blood extracellular vesicle protein  biomarkers for hepatocellular carcinoma: mechanisms, methods, and translation  \nYijia Zhuang1,2†, Wenjuan Zeng1,3†, Tingting Long4†, Nan Gao2, Weitao Zhong2, Hongyu Mu1, Xinyuan Wang3 and Hao Yang1,2,3,5,6*  \nAbstract  \nHepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally, with late-stage diagnoses predominantly driven by the absence of early clinical symptoms and the inadequate sensitivity of current diagnostic tools, highlighting a critical unmet need in liver cancer management. Circulating extracellular vesicles (EVs), which naturally carry proteins and nucleic acids, serve as both mediators of tumor-specific biology and reporters of early pathophysiological changes, offering a transformative avenue for noninvasive liquid biopsy. This review integrates mechanistic advances in understanding EV-associated proteins involved in HCC pathogenesis with state-of-the-art proteomic methodologies for EV biomarker discovery, validation, and clinical translation. We highlight how functional and mechanistic insights into EV proteins guide the identification of clinically relevant biomarkers and examine recent progress in analytical approaches for isolating and profiling blood-derived EVsin large patient cohorts. Additionally, we discuss the development of high-throughput detection platforms, such as biochip-based assays, which are accelerating the translation of EV protein biomarkers from research to routine clinical practice. Critical challenges, including the lack of standardized analytical workflows, limited demonstration of clinical utility, and the need for multicenter validation, are addressed, with a focus on strategies to ensure robust and reproducible biomarker performance. By bridging mechanistic understanding with analytical innovation and clinical application, we aim to accelerate the deployment of EV proteomics for earlier HCC detection, risk stratification, and treatment monitoring, ultimately advancing precision oncology.  \nKeywords Hepatocellular carcinoma, Extracellular vesicles, Proteomics, Protein biomarkers, Liquid biopsy  \n†Yijia Zhuang, Wenjuan Zeng and Tingting Long contributed equally to this work.  \n*Correspondence: Hao Yang [yanghao@scu.edu.cn](yanghao@scu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nZhuang et al. Journal of Nanobiotechnology (2026) 24:515 Page 2 of 24  \nGraphical abstract  \nIntroduction  \nLiver cancer ranks as the sixth most prevalent malignancy worldwide and the third leading cause of cancerrelated mortality, following lung and colorectal cancers [1","cbCaiiHGOCznzmiy","https://ap.wps.com/l/cbCaiiHGOCznzmiy","pdf",2198943,24,"English","# Introduction\n## Clinical need and epidemiology\n## Current diagnostic landscape and surveillance strategies\n# Review focus and biomarker development","[{\"question\":\"Why are early detection tools for hepatocellular carcinoma still insufficient?\",\"answer\":\"HCC is often diagnosed at intermediate or advanced stages because early clinical symptoms are insidious and current diagnostic tools lack sufficient sensitivity.\"},{\"question\":\"How do blood extracellular vesicles support noninvasive biomarker discovery?\",\"answer\":\"Circulating EVs naturally transport proteins and nucleic acids that reflect tumor-specific biology and early pathological changes, making them suitable reporters for liquid biopsy.\"},{\"question\":\"What does the review cover to advance EV protein biomarkers toward clinical translation?\",\"answer\":\"It integrates mechanistic advances on EV-associated proteins with state-of-the-art proteomic methods for discovery, validation, analytical profiling in cohorts, and development of high-throughput detection platforms such as biochip-based assays.\"}]","Developing blood extracellular vesicle protein biomarkers for hepatocellular carcinoma - mechanisms, methods, and translation | PDF",1790151823,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2069795617923f99993f29759585a35e.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a0179c8595632773e79b12a385820af.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e88b455f978f9d40de09a95a86617cd3.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f889ae2a2778219f4c991430670c4648.webp",980,1306]